Shri Ahimsa Naturals Limited's Board of Directors, at its meeting held on Tuesday, May 12, 2026, approved the allotment of 3,77,600 (Three Lakhs Seventy Seven Thousand Six Hundred) fully paid-up equity shares of face value ₹10/- each at an issue price of ₹227/- per share (including a premium of ₹217/- per share). The allotment was made pursuant to the conversion of an equivalent number of convertible warrants, following receipt of the balance 75% of the warrant issue price from the respective warrant holders. This development was disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was in furtherance to the approval granted by members at the Extra-Ordinary General Meeting held on November 26, 2025.

Warrant Conversion and Allotment Details

The warrants were originally allotted on January 13, 2026, at a price of ₹227/- each, with 25% of the issue price received at the time of subscription. The balance 75% was received from the warrant holders prior to the current allotment. The total amount received towards the 75% balance across all allottees aggregated to ₹6,42,86,400. The following table summarises the allotment details for each warrant holder:

Investor Categories and Shareholding Impact

The allotment was made to four investors — two classified as promoters (Nemi Chand Jain and Amit Kumar Jain) and two as non-promoters (NKA Resources LLP and Sajal Family Trust). The issuance was carried out as a preferential allotment in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws. The table below presents the pre- and post-allotment equity holding positions for each allottee:

Impact on Paid-Up Capital

Subsequent to the allotment, the issued, subscribed, and paid-up capital of Shri Ahimsa Naturals has increased as detailed below:

The newly allotted equity shares rank pari-passu with the existing equity shares of the company in all respects. The Board meeting commenced at 5:00 PM and concluded at 6:45 PM on May 12, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.

Shri Ahimsa Naturals Limited has submitted a regulatory disclosure to the National Stock Exchange of India regarding the encumbrance status of promoter shareholding. The disclosure was made under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, and dated April 02, 2026.

Key Disclosure Details

The disclosure was submitted by Sumitra Jain, who serves as Promoter and Director of shri ahimsa naturals . In her declaration, Jain confirmed that she holds 16,04,400 equity shares in the company. The declaration specifically pertains to the financial year ended March 31, 2026.

Declaration Summary

Encumbrance Status

Sumitra Jain declared that she, along with persons acting in concert, has not made any encumbrance, directly or indirectly, on her shareholding during the specified financial year. The disclosure explicitly states that no encumbrances were created other than those that had already been disclosed previously. This confirmation was submitted to both the Listing Compliance Department of the National Stock Exchange of India and the Audit Committee of Shri Ahimsa Naturals Limited for record-keeping purposes.